The Totaled Health Risks in Vascular Events ( THRIVE ) score strongly predicts clinical outcome , mortality , and risk of thrombolytic haemorrhage in ischemic stroke patients , and performs similarly well in patients receiving intravenous tissue plasminogen activator , endovascular stroke treatment , or no acute treatment .